Phase 1 Trial: Safety & Immunogenicity of mRNA-1215 Nipah Vaccine in Healthy Adults
A new phase 1 clinical trial has been initiated to evaluate the safety and effectiveness of an mRNA vaccine designed to combat the Nipah virus (NiV), a zoonotic pathogen that poses significant health risks in certain regions. This trial, known as mRNA-1215, aims to assess its immunogenicity and tolerability in healthy adults aged 18 to … Read more